These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 20701064

  • 1. Assessment of fluorescence in situ hybridization and hybrid capture 2 analyses of cervical cytology specimens diagnosed as low grade squamous intraepithelial lesion for the detection of high grade cervical intraepithelial neoplasia.
    Voss JS, Kipp BR, Campion MB, Sokolova IA, Henry MR, Halling KC, Clayton AC.
    Anal Quant Cytol Histol; 2010 Jun; 32(3):121-30. PubMed ID: 20701064
    [Abstract] [Full Text] [Related]

  • 2. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.
    Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S.
    Asian Pac J Cancer Prev; 2014 Jun; 15(24):10961-6. PubMed ID: 25605209
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia.
    Guo M, Hu L, Baliga M, He Z, Hughson MD.
    Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
    Obermann EC, Savic Prince S, Barascud A, Grilli B, Herzog M, Kaup D, Cathomas G, Frey Tirri B, Zlobec I, Wight E, Bubendorf L.
    Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
    [Abstract] [Full Text] [Related]

  • 8. Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.
    Carozzi F, Bisanzi S, Sani C, Zappa M, Cecchini S, Ciatto S, Confortini M.
    J Clin Microbiol; 2007 Feb; 45(2):364-9. PubMed ID: 17122008
    [Abstract] [Full Text] [Related]

  • 9. Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.
    De Vivar AD, Dawlett M, Wang JP, Jack A, Gong Y, Staerkel G, Guo M.
    Arch Pathol Lab Med; 2015 Feb; 139(2):219-24. PubMed ID: 25611104
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E.
    Int J Gynecol Cancer; 2006 Feb; 16(2):591-8. PubMed ID: 16681731
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Evaluation of gene chip technology for high risk type human papillomavirus in cervical cancer screening].
    Li RZ, Shi JF, Zhou QZ, Wu RF, Li N, Wu LN, Zhou YQ, Wang Q, Liu ZH, Liu B, Qiao YL.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 07; 86(5):307-11. PubMed ID: 16677522
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: Implications for vaginal self-collection.
    Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL.
    Int J Cancer; 2010 Sep 01; 127(5):1151-7. PubMed ID: 20039323
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
    Dane C, Batmaz G, Dane B, Cetin A.
    Ann Diagn Pathol; 2009 Apr 01; 13(2):73-7. PubMed ID: 19302953
    [Abstract] [Full Text] [Related]

  • 17. [Clinical value of p16INK4a immunocytochemistry in cervical cancer screening].
    Song FB, Du H, Xiao AM, Wang C, Huang X, Yan PS, Liu ZH, Qu XF, Belinson JEROMEL, Wu RF.
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov 25; 55(11):784-790. PubMed ID: 33228350
    [Abstract] [Full Text] [Related]

  • 18. [Use of high-risk human papillomavirus DNA testing to deal with atypical squamous cells undetermined significance and low squamous intraepithelial lesion].
    Guo YL, You K, Geng L, Zhang XW, Shen XY, Yao YJ, Fan XH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct 18; 38(5):480-2. PubMed ID: 17068618
    [Abstract] [Full Text] [Related]

  • 19. Human papillomavirus testing with a liquid-based system: feasibility and comparison with reference diagnoses.
    Bergeron C, Cas F, Fagnani F, Didailler-Lambert F, Poveda JD.
    Acta Cytol; 2006 Oct 18; 50(1):16-22. PubMed ID: 16514835
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.